Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: ZNN Bactiguard Antegrade Femoral Nails PMCF Study

View source ↗

Summary

A post-market clinical follow-up study of ZNN Bactiguard Antegrade Femoral Nails is currently recruiting to evaluate outcomes in femur fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZNN Bactiguard Antegrade Femoral Nails

Snippet

Sponsor: Zimmer Biomet | Conditions: Femur Fracture, Osteotomy | Status: RECRUITING